AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Interest & Investment Income came in at $78000.0 in Q1 2026, down 58.06% year-on-year from $186000.0 in Q1 2025, and down 58.06% quarter-over-quarter from $186000.0 in Q1 2025.
AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Interest & Investment Income data on file, last reported at $504000.0 in Q3 2025.
- For the quarter ending Q3 2025, Interest & Investment Income rose 215.0% year-over-year to $504000.0; the trailing twelve-month figure through Sep 2025 stood at $1.1 million (down 8.86% YoY), and the FY2024 full-year result was $778000.0, down 57.88% from the prior year.
- Interest & Investment Income eased to $78000.0 in Q1 2026 per ATAI's latest filing, from $186000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $186000.0 in Q1 2025 and bottomed at $78000.0 in Q1 2026.
- A 5-year average of $227052.6 and a median of $186000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 1712.5% in 2022 and sank 73.86% in 2024, its largest moves.
- Tracing ATAI's Interest & Investment Income over 5 years: stood at $125000.0 in 2021, then jumped by 49.6% to $187000.0 in 2022, then soared by 250.8% to $656000.0 in 2023, then tumbled by 70.58% to $193000.0 in 2024, then jumped by 161.14% to $504000.0 in 2025.
- Business Quant data shows ATAI's Interest & Investment Income at $504000.0 in Q3 2025, $248000.0 in Q2 2025, and $186000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | AtaiBeckley | 1.56 Bn | 1.56 Bn | - | 504,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 248,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 612,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 275,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 35,000.00 |